PuSH - Publication Server of Helmholtz Zentrum München: Empagliflozin as metabolically active compound for treatment of non-alcoholic fatty liver disease in type 2 diabetes.

Navigation

Home

Deutsch

Research

Advanced Search

Browse by ...

... Journal

... Publication Type

... Research Data

... Publication Year

Publication overview

Support & Contact

Contact persons

Help

Data protection

Kahl, S.* ; Gancheva, S.* ; Strassburger, K.* ; Herder, C.* ; Machann, J. ; Kupriyanova, Y.* ; Kabisch, S.* ; Henkel, E.* ; Kantartzis, K. ; Kopf, S.* ; Kasperk, C.* ; Stefan, N. ; Pfeiffer, A.* ; Birkenfeld, A.L.* ; Roden, M.*

Empagliflozin as metabolically active compound for treatment of non-alcoholic fatty liver disease in type 2 diabetes.

Diabetologia 62, S124-S124 (2019)

Open Access Green as soon as Postprint is submitted to ZB.

Abstract
Metrics
Extra information

Additional Metrics?

[➜Log in]

Edit extra informations Login

Publication type Article: Journal article

Document type Meeting abstract

Corresponding Author

ISSN (print) / ISBN 0012-186X

e-ISSN 1432-0428

Journal Diabetologia

Quellenangaben Volume: 62, Pages: S124-S124

Publisher Springer

Publishing Place Berlin ; Heidelberg [u.a.]

Non-patent literature Publications

Reviewing status Peer reviewed

Institute(s) Institute of Diabetes Research and Metabolic Diseases (IDM)